242
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Correlation between cognition and symptomatic severity in patients with late-life somatoform disorders

, , , , &
Pages 169-174 | Received 07 Oct 2013, Accepted 22 Apr 2014, Published online: 29 May 2014

References

  • Al-Lawati, J., Al-Lawati, N., Al-Siddiqui, M., Antony, S.X., Al-Naamani, A., Martin, R.G., … Al-Adawi, S. (2000). Psychological morbidity in primary healthcare in Oman: A preliminary study. Journal for Scientific Research: Medical Sciences, 2, 105–110.
  • Altamura, A.C., Carta, M.G., Tacchini, G., Musazzi, A., & Pioli, M.R. (1998). Prevalence of somatoform disorders in a psychiatric population: An Italian nationwide survey. Italian Collaborative Group on Somatoform Disorders. European Archives of Psychiatry and Clinical Neuroscience, 248, 267–271.
  • American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR (4th edition, text revision). Washington, DC: American Psychiatric Association.
  • Barch, D.M., DʼAngelo, G., Pieper, C., Wilkins, C.H., Welsh-Bohmer, K., Taylor, W., … Sheline, Y.I. (2012). Cognitive improvement following treatment in late-life depression: Relationship to vascular risk and age of onset. American Journal of Geriatric Psychiatry, 20, 682–690.
  • Beaudreau, S.A., & O’Hara, R. (2008). Late-life anxiety and cognitive impairment: A review. American Journal of Geriatric Psychiatry, 16, 790–803.
  • Buckner, R.L. (2004). Memory and executive function in aging and AD: Multiple factors that cause decline and reserve factors that compensate. Neuron, 44, 195–208.
  • Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000) The FAB: A Frontal Assessment Battery at bedside. Neurology, 55, 1621–1626.
  • Folstein, M.F., Folstein, S.E., & McHugh, P.R. (1975) ‘Mini-mental state examination’. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
  • Gupta, A., & Kumar, N.K. (2009). Indian adaptation of the Cognistat: Psychometric properties of a cognitive screening tool for patients of traumatic brain injury. The Indian Journal of Neurotrauma, 6, 123–132.
  • Hall, N.M., Kuzminskyte, R., Pedersen, A.D., Ørnbøl, E., & Fink, P. (2011). The relationship between cognitive functions, somatization and behavioural coping in patients with multiple functional somatic symptoms. Nordic Journal of Psychiatry, 65, 216–224.
  • Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50–55.
  • Harwood, R.H., Prince, M.J., Mann, A.H., & Ebrahim, S. (1998). The prevalence of diagnoses, impairments, disabilities and handicaps in a population of elderly people living in a defined geographical area: The Gospel Oak project. Age and ageing, 27, 707–714.
  • Inagaki, A., & Inada, T. (1999). Dose equivalence of psychometric drugs. Tokyo: Seiwa Shoten. [In Japanese].
  • Kashyap, H., Kumar, J.K., Kandavel, T., & Reddy, Y.C. (2012). Neuropsychological correlates of insight in obsessive-compulsive disorder. Acta Psychiatrica Scandinavica, 126, 106–114.
  • Kuwabara, H., Otsuka, M., Shindo, M., Ono. S., Shioiri. T., & Someya T. (2007). Diagnostic classification and demographic features in 283 patients with somatoform disorder. Psychiatry and Clinical Neurosciences, 61, 283–289.
  • Lipowski, Z.J. (1988). Somatization: The concept and its clinical application. American Journal of Psychiatry, 145, 1358–1368.
  • Maier, W., Buller, R., Philipp, M., & Heuser, I. (1988). The Hamilton Anxiety Scale: Reliability, validity and sensitivity to change in anxiety and depressive disorders. Journal of Affective Disorders, 14, 61–68.
  • Matsuda, O., & Nakatani, N. (2004). Manual for Japanese version of the Neurobehavioral Cognitive Status Examination (COGNISTAT). Tokyo: World Planning. [In Japanese].
  • Matsuda, O., & Saito, M. (2009). Multiple cognitive deficits in patients during the mild cognitive impairment stage of Alzheimer's disease: How are cognitive domains other than episodic memory impaired? International Psychogeriatrics, 21, 970–976.
  • Mayou, R., Bass, C., & Sharpe, M. (1995). Overview of epidemiology classification and aetiology. In R. Mayou, C. Bass, & M. Sharpe (Eds.), Treatment of functional somatic symptoms (pp. 42–65). Oxford: Oxford University Press.
  • Müller, T., Mannel, M., Murck, H., & Rahlfs, V.W. (2004). Treatment of somatoform disorders with St. John's wort: A randomized, double-blind and placebo-controlled trial. Psychosomatic medicine, 66, 538–554.
  • Nagata, T., Ishii, K., Ito, T., Aoki, K., Ehara, Y., Kada, H., … Nakayama, K. (2009). Correlation between a reduction in Frontal Assessment Battery scores and delusional thoughts in patients with Alzheimer's disease. Psychiatry and Clinical Neurosciences, 63, 449–454.
  • Nilsson, L.G. (2003). Memory function in normal aging. Acta Neurologica Scandinavica, 179, 7–13.
  • Petersen, R.C., Doody, R., Kurz, A., Mohs, R.C., Morris, J.C., Rabins, P.V., … Winblad, B. (2001) Current concepts in mild cognitive impairment. Archives of Neurology, 58, 1985–1992.
  • Salkovskis, P.M., & Warwick, H.M. (2001). Meaning, misinterpretations, and medicine: A cognitive behavioral approach to understanding health anxiety and hypochondriasis. In V. Starcevic, & D.R. Lipsitt (Eds.), Hypochondriasis: Modern perspectives on an ancient malady (pp. 202–222). Oxford: Oxford University Press.
  • Sheehan, B., Bass, C., Briggs, R., & Jacoby, R. (2003). Somatization among older primary care attenders. Psychological Medicine, 33, 867–877.
  • Stewart, S.A. (2005). The effects of benzodiazepines on cognition: Review. Journal of Clinical Psychiatry, 66 ( Suppl.), 9–13.
  • Volz, H.P., Möller, H.J., Reimann, I., & Stoll, K.D. (2000). Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial. European Neuropsychopharmacology, 10, 211–217.
  • Volz, H.P., Murck, H., Kasper, S., & Möller, H.J. (2002). St John's wort extract (LI 160) in somatoform disorders: Results of a placebo-controlled trial. Psychopharmacology (Berl), 164, 294–300.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.